ARTICLE | Clinical News
Lipofen fenofibrate capsules regulatory update
January 16, 2006 8:00 AM UTC
FDA approved an NDA for 50, 100 and 150 mg Lipofen gelatine capsules containing fenofibrate as an adjunctive therapy to diet to reduce elevated LDL-C, total cholesterol, triglycerides, apolipoprotein...